Retail Roundup

Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

As a trusted healthcare resource that also happens to be one of the most accessible and affordable in the community, pharmacists are well positioned to help consumers with their care management needs and guide them toward better o...

View Blog Post
Blog Post

A recently published report by authors from the Centers for Disease Control and Prevention (CDC) states that in 2011, general dentists prescribed 10% of all antibiotics in the community. This compares to: ...

View Blog Post
Blog Post

Pharmacy has long been at the forefront of the electronic exchange of information. It started with the first claims submission decades ago and followed with the advent of electronic prescribing. But now, pharmacy may be at risk of...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up